Oral drug Molnupiravir effective against COVID-19 in hamsters: study
The Hindu
The drug was effective when provided up to 12 hours before or 12 hours after infection with SARS-CoV-2
An orally administered antiviral drug initially developed to treat influenza can significantly decrease novel coronavirus levels in hamsters, holding out promise of a pill to combat COVID-19, say researchers. Scientists from the National Institutes of Health (NIH) in the U.S. and the University of Plymouth in the U.K. found that MK-4482, also called Molnupiravir, was effective when provided up to 12 hours before or 12 hours after infection with SARS-CoV-2, the novel coronavirus that causes COVID-19. The drug can also decrease damage it causes to lungs, states the study conducted on hamsters.More Related News

On January 11, 1922, 14-year-old Leonard Thompson became the first person to receive an insulin injection as a treatment for diabetes. A disease that had haunted humankind for millennia finally became treatable, and the century since has seen a lot happen, both good and bad. A.S.Ganesh takes stock of a disease that is now unfolding as a global epidemic…












